Annual SG&A
$34.75 M
+$4.54 M+15.02%
31 December 2023
Summary:
Tonix Pharmaceuticals Holding annual selling, general & administrative expenses is currently $34.75 million, with the most recent change of +$4.54 million (+15.02%) on 31 December 2023. During the last 3 years, it has risen by +$20.40 million (+142.11%). TNXP annual SG&A is now at all-time high.TNXP Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$7.71 M
+$205.00 K+2.73%
30 September 2024
Summary:
Tonix Pharmaceuticals Holding quarterly selling, general & administrative expenses is currently $7.71 million, with the most recent change of +$205.00 thousand (+2.73%) on 30 September 2024. Over the past year, it has dropped by -$1.00 million (-11.54%). TNXP quarterly SG&A is now -33.68% below its all-time high of $11.62 million, reached on 31 December 2023.TNXP Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$2.62 B
-$135.25 M-5.44%
30 September 2024
Summary:
Tonix Pharmaceuticals Holding TTM selling, general & administrative expenses is currently -$2.62 billion, with the most recent change of -$135.25 million (-5.44%) on 30 September 2024. Over the past year, it has dropped by -$2.65 billion (-8499.49%). TNXP TTM SG&A is now -26192040.00% below its all-time high of $37.15 million, reached on 30 June 2024.TNXP TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNXP Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +15.0% | -11.5% | -8499.5% |
| 3 y3 years | +142.1% | +41.3% | -10000.0% |
| 5 y5 years | +296.5% | +171.5% | -10000.0% |
TNXP Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +142.1% | -33.7% | +41.3% | -118.7% | at low |
| 5 y | 5 years | at high | +296.5% | -33.7% | +194.1% | -230.7% | at low |
| alltime | all time | at high | >+9999.0% | -33.7% | >+9999.0% | <-9999.0% | at low |
Tonix Pharmaceuticals Holding Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $7.71 M(+2.7%) | $36.14 M(-2.7%) |
| June 2024 | - | $7.50 M(-19.4%) | $37.15 M(+1.3%) |
| Mar 2024 | - | $9.31 M(-19.9%) | $36.67 M(+5.5%) |
| Dec 2023 | $34.75 M(+15.0%) | $11.62 M(+33.4%) | $34.75 M(+11.4%) |
| Sept 2023 | - | $8.71 M(+24.0%) | $31.18 M(+4.4%) |
| June 2023 | - | $7.03 M(-4.9%) | $29.86 M(+0.9%) |
| Mar 2023 | - | $7.39 M(-8.2%) | $29.59 M(-2.1%) |
| Dec 2022 | $30.21 M(+28.7%) | $8.05 M(+9.0%) | $30.21 M(+3.0%) |
| Sept 2022 | - | $7.39 M(+9.4%) | $29.34 M(+7.1%) |
| June 2022 | - | $6.76 M(-15.7%) | $27.41 M(+5.1%) |
| Mar 2022 | - | $8.01 M(+11.6%) | $26.08 M(+11.1%) |
| Dec 2021 | $23.47 M(+63.5%) | $7.18 M(+31.7%) | $23.47 M(+10.6%) |
| Sept 2021 | - | $5.45 M(+0.4%) | $21.22 M(+12.0%) |
| June 2021 | - | $5.43 M(+0.4%) | $18.95 M(+10.5%) |
| Mar 2021 | - | $5.41 M(+9.8%) | $17.14 M(+19.4%) |
| Dec 2020 | $14.35 M(+35.0%) | $4.93 M(+54.6%) | $14.35 M(+15.1%) |
| Sept 2020 | - | $3.19 M(-12.0%) | $12.47 M(+2.9%) |
| June 2020 | - | $3.62 M(+38.2%) | $12.13 M(+11.7%) |
| Mar 2020 | - | $2.62 M(-13.9%) | $10.86 M(+2.1%) |
| Dec 2019 | $10.64 M(+21.4%) | $3.04 M(+7.2%) | $10.64 M(+4.4%) |
| Sept 2019 | - | $2.84 M(+20.7%) | $10.19 M(+5.8%) |
| June 2019 | - | $2.35 M(-2.0%) | $9.62 M(+3.0%) |
| Mar 2019 | - | $2.40 M(-7.4%) | $9.35 M(+6.7%) |
| Dec 2018 | $8.76 M(+10.3%) | $2.59 M(+13.9%) | $8.76 M(+8.5%) |
| Sept 2018 | - | $2.28 M(+9.7%) | $8.08 M(+4.5%) |
| June 2018 | - | $2.08 M(+14.2%) | $7.73 M(+0.8%) |
| Mar 2018 | - | $1.82 M(-4.8%) | $7.67 M(-3.5%) |
| Dec 2017 | $7.95 M(-23.8%) | $1.91 M(-0.9%) | $7.95 M(-8.3%) |
| Sept 2017 | - | $1.93 M(-4.4%) | $8.67 M(-2.4%) |
| June 2017 | - | $2.02 M(-3.9%) | $8.89 M(-3.3%) |
| Mar 2017 | - | $2.10 M(-20.3%) | $9.19 M(-11.9%) |
| Dec 2016 | $10.44 M | $2.63 M(+22.7%) | $10.44 M(-10.9%) |
| Sept 2016 | - | $2.14 M(-7.6%) | $11.72 M(-6.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2016 | - | $2.32 M(-30.6%) | $12.54 M(-4.5%) |
| Mar 2016 | - | $3.34 M(-14.5%) | $13.13 M(+3.8%) |
| Dec 2015 | $12.66 M(+40.0%) | $3.91 M(+31.9%) | $12.66 M(+5.7%) |
| Sept 2015 | - | $2.97 M(+1.8%) | $11.97 M(+6.7%) |
| June 2015 | - | $2.91 M(+1.6%) | $11.23 M(+9.1%) |
| Mar 2015 | - | $2.87 M(-11.2%) | $10.29 M(+13.8%) |
| Dec 2014 | $9.04 M(+44.9%) | $3.23 M(+45.6%) | $9.04 M(+10.4%) |
| Sept 2014 | - | $2.22 M(+12.3%) | $8.19 M(+10.3%) |
| June 2014 | - | $1.97 M(+21.9%) | $7.43 M(+12.6%) |
| Mar 2014 | - | $1.62 M(-32.0%) | $6.60 M(+5.8%) |
| Dec 2013 | $6.24 M(+53.0%) | $2.38 M(+63.6%) | $6.24 M(+23.0%) |
| Sept 2013 | - | $1.46 M(+27.4%) | $5.07 M(+8.1%) |
| June 2013 | - | $1.14 M(-9.4%) | $4.69 M(+2.6%) |
| Mar 2013 | - | $1.26 M(+3.6%) | $4.58 M(+12.2%) |
| Dec 2012 | $4.08 M(+83.7%) | $1.22 M(+13.0%) | $4.08 M(+6.4%) |
| Sept 2012 | - | $1.08 M(+5.2%) | $3.83 M(+16.9%) |
| June 2012 | - | $1.02 M(+34.2%) | $3.28 M(+28.7%) |
| Mar 2012 | - | $762.70 K(-21.4%) | $2.55 M(+14.8%) |
| Dec 2011 | $2.22 M(+65.2%) | $970.90 K(+85.8%) | $2.22 M(-14.0%) |
| Sept 2011 | - | $522.50 K(+78.4%) | $2.58 M(+25.1%) |
| June 2011 | - | $292.80 K(-32.6%) | $2.06 M(+16.4%) |
| Mar 2011 | - | $434.20 K(-67.4%) | $1.77 M(+31.9%) |
| Dec 2010 | $1.34 M(+9571.9%) | $1.33 M(>+9900.0%) | $1.34 M(+8629.9%) |
| Sept 2010 | - | $3700.00(+54.2%) | $15.40 K(+7.7%) |
| June 2010 | - | $2400.00(-58.6%) | $14.30 K(-17.3%) |
| Mar 2010 | - | $5800.00(+65.7%) | $17.30 K(+24.5%) |
| Dec 2009 | $13.90 K(-0.7%) | $3500.00(+34.6%) | $13.90 K(+3.0%) |
| Sept 2009 | - | $2600.00(-51.9%) | $13.50 K(-6.9%) |
| June 2009 | - | $5400.00(+125.0%) | $14.50 K(+0.7%) |
| Mar 2009 | - | $2400.00(-22.6%) | $14.40 K(+2.9%) |
| Dec 2008 | $14.00 K | $3100.00(-13.9%) | $14.00 K(+28.4%) |
| Sept 2008 | - | $3600.00(-32.1%) | $10.90 K(+49.3%) |
| June 2008 | - | $5300.00(+165.0%) | $7300.00(+265.0%) |
| Mar 2008 | - | $2000.00 | $2000.00 |
FAQ
- What is Tonix Pharmaceuticals Holding annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding annual SG&A year-on-year change?
- What is Tonix Pharmaceuticals Holding quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding quarterly SG&A year-on-year change?
- What is Tonix Pharmaceuticals Holding TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding TTM SG&A year-on-year change?
What is Tonix Pharmaceuticals Holding annual selling, general & administrative expenses?
The current annual SG&A of TNXP is $34.75 M
What is the all time high annual SG&A for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high annual selling, general & administrative expenses is $34.75 M
What is Tonix Pharmaceuticals Holding annual SG&A year-on-year change?
Over the past year, TNXP annual selling, general & administrative expenses has changed by +$4.54 M (+15.02%)
What is Tonix Pharmaceuticals Holding quarterly selling, general & administrative expenses?
The current quarterly SG&A of TNXP is $7.71 M
What is the all time high quarterly SG&A for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high quarterly selling, general & administrative expenses is $11.62 M
What is Tonix Pharmaceuticals Holding quarterly SG&A year-on-year change?
Over the past year, TNXP quarterly selling, general & administrative expenses has changed by -$1.00 M (-11.54%)
What is Tonix Pharmaceuticals Holding TTM selling, general & administrative expenses?
The current TTM SG&A of TNXP is -$2.62 B
What is the all time high TTM SG&A for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high TTM selling, general & administrative expenses is $37.15 M
What is Tonix Pharmaceuticals Holding TTM SG&A year-on-year change?
Over the past year, TNXP TTM selling, general & administrative expenses has changed by -$2.65 B (-8499.49%)